ArticleJournal of imaging2025
Lung Nodule Malignancy Classification Integrating Deep and Radiomic Features in a Three-Way Attention-Based Fusion Module.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- A methodological framework for integrating generalisable deep learning and radiomics fusion model for early lung cancer detection across multi-centre imaging datasets.BMC medical informatics and decision making · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we propose a novel hybrid framework for assessing the invasiveness of an in-house dataset of 114 pathologically proven lung adenocarcinomas presenting as subsolid nodules on Computed Tomography (CT). Nodules were classified into group 1 (G1), which included atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinomas, and group 2 (G2), which included invasive adenocarcinomas. Our approach includes a three-way Integration of Visual, Spatial, and Temporal features with Attention, referred to as I-VISTA, obtained from three processing algorithms designed based on Deep Learning (DL) and radiomic models, leading to a more comprehensive analysis of nodule variations. The aforementioned processing algorithms are arranged in the following three parallel paths: (i) The Shifted Window (SWin) Transformer path, which is a hierarchical vision Transformer that extracts nodules' related spatial features; (ii) The Convolutional Auto-Encoder (CAE) Transformer path, which captures informative features related to inter-slice relations via a modified Transformer encoder architecture; and (iii) a 3D Radiomic-based path that collects quantitative features based on texture analysis of each nodule. Extracted feature sets are then passed through the Criss-Cross attention fusion module to discover the most informative feature patterns and classify nodules type. The experiments were evaluated based on a ten-fold cross-validation scheme. I-VISTA framework achieved the best performance of overall accuracy, sensitivity, and specificity (mean ± std) of 93.93 ± 6.80%, 92.66 ± 9.04%, and 94.99 ± 7.63% with an Area under the ROC Curve (AUC) of 0.93 ± 0.08 for lung nodule classification among ten folds. The hybrid framework integrating DL and hand-crafted 3D Radiomic model outperformed the standalone DL and hand-crafted 3D Radiomic model in differentiating G1 from G2 subsolid nodules identified on CT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.